VARANT ARZOUMANIAN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FORT SMITH, AR NPI 1790904027
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AR PFIZER INC. All categories
General Payments — all program years on this page
$7,123.50
- Category: General Payments
- Program years: PY2018–2024
- Record count: 454
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,403.41 across 82 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,312.36 | 74 |
| Education | $91.05 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $245.87 | 21 |
| Acerta Pharma LLC | $188.71 | 11 |
| Daiichi Sankyo Inc. | $180.85 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $164.85 | 7 |
| Gilead Sciences, Inc. | $98.45 | 6 |
| GlaxoSmithKline, LLC. | $97.74 | 6 |
| Rigel Pharmaceuticals, Inc. | $88.98 | 5 |
| Merck Sharp & Dohme Corporation | $65.79 | 3 |
| ABBVIE INC. | $46.63 | 3 |
| PUMA BIOTECHNOLOGY, INC. | $37.82 | 2 |
| Janssen Biotech, Inc. | $35.62 | 2 |
| Astellas Pharma US Inc | $34.89 | 2 |
| Sumitomo Pharma America, Inc. | $25.65 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.49 | 1 |
| MENARINI SILICON BIOSYSTEMS, INC. | $19.79 | 1 |
| Celgene Corporation | $18.03 | 1 |
| Ipsen Biopharmaceuticals, Inc | $16.23 | 1 |
| EMD Serono, Inc. | $14.02 | 1 |
By program year
Records — PY2024 (82)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.